SCHEMBL24463199

SCHEMBL24463199

CN(C)c1nc2cc(I)ccc2n1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 2/20 0.40
HDAC6 Q9UBN7 2/20 0.37
APP P05067 4/20 0.35
KDM4E B2RXH2 3/20 0.34
HSD17B10 Q99714 2/20 0.34
MAPT P10636 5/20 0.33
ALDH1A1 P00352 4/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
LMNA P02545 2/20 0.33
NPC1 O15118 2/20 0.33
TP53 P04637 2/20 0.33
RAB9A P51151 2/20 0.33
PKM P14618 1/20 0.33
HPGD P15428 1/20 0.33
HTT P42858 1/20 0.33
GFER P55789 1/20 0.33
CSNK2A2 P19784 1/20 0.32
CSNK2B P67870 1/20 0.32
CSNK2A1 P68400 1/20 0.32
MEN1 O00255 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6604741 0.79 KDM4E (0.45) MCHR1HDAC6KDM4EHSD17B10MAPT
SCHEMBL12402264 0.79 MAPT (0.50) MCHR1HDAC6KDM4EHSD17B10MAPT
SCHEMBL6607679 0.79 MCHR1 (0.40) MCHR1HDAC6KDM4EHSD17B10MAPT
SCHEMBL17561688 0.77 KDM4E (0.55) KDM4EHSD17B10MAPTALDH1A1SMN1; SMN2
SCHEMBL14364730 0.75 ALDH1A1 (0.65) HDAC6APPKDM4EHSD17B10MAPT
SCHEMBL30490151 0.75 ALOX15 (0.35) HDAC6KDM4EHSD17B10MAPTALDH1A1
SCHEMBL24463198 0.75 CLK4 (0.41) APPKDM4EHSD17B10MAPTALDH1A1
SCHEMBL14685203 0.74 SMN1; SMN2 (0.57) KDM4EHSD17B10MAPTALDH1A1SMN1; SMN2
SCHEMBL32661807 0.73 CA12 (0.45) MCHR1HDAC6ALDH1A1LMNANPC1
SCHEMBL23071666 0.72 MAPT (0.40) HDAC6KDM4EMAPTALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116057045-A Fibroblast growth factor receptor kinase inhibitors 金耐特生物制药公司 2023-05-02 CN disclosed
EP-4161656-A1 INHIBITORS OF FIBROBLAST GROWTH FACTOR RECEPTOR KINASES Kinnate Biopharma Inc. (US) 2023-04-12 EP disclosed
US-11345681-B1 Inhibitors of fibroblast growth factor receptor kinases KINNATE BIOPHARMA INC. (US) 2022-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11345681-B1 Inhibitors of fibroblast growth factor receptor kinases FGFR1, FGFR2, FGFR3 MCHR1 4516/4885HDAC6 746/4885APP 4029/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.